for Journals by Title or ISSN
for Articles by Keywords
help
Followed Journals
Journal you Follow: 0
 
Sign Up to follow journals, search in your chosen journals and, optionally, receive Email Alerts when new issues of your Followed Jurnals are published.
Already have an account? Sign In to see the journals you follow.
Medtech Insight
   Follow    
   Full-text available via subscription Subscription journal
     ISSN (Print) 1876-8008
     Published by Informa plc Homepage  [13 journals]
  • ESC 2014 Shines Spotlight On The Future Of Cardiology
    • Abstract: The cardiology sector, long known as one of the most innovative in medtech, has a new wave of technologies on the horizon that could help reinvigorate the sector and create new multibillion-dollar market opportunities for device manufacturers. We take a closer look at these technologies, which include vagal nerve stimulation, remote monitoring for heart failure, as well as innovation in the percutaneous coronary intervention space, all of which were all in the spotlight at the recent European Society of Cardiology Congress 2014 in Barcelona.
      PubDate: Thu, 30 Oct 2014 00:05:34 -040
       
  • Digital Health Pushing Telemedicine To Center Stage
    • Abstract: Remote monitoring is proving to be the driving force in the industry’s quest to reduce costs by keeping patients out of hospitals, and telemedicine is positioned to become a major part of that scheme. However, telemedicine has a number of components and players, and while the market offers opportunities, it could also prove to be somewhat disruptive to companies and products that do not fit in the envisioned landscape.
      PubDate: Thu, 30 Oct 2014 00:05:19 -040
       
  • Oxford Performance Materials: Is 3D Printing The New Face Of
           Orthopedics'
    • Abstract: With FDA approval of facial and cranial implants, Oxford Performance Materials, a materials and additive manufacturing (3D printing) company, is working to become a full service orthopedic and spinal company in the coming years.
      PubDate: Thu, 30 Oct 2014 00:05:06 -040
       
  • Stenting And Thrombectomy Systems Fuel Neuro Device Market Growth
    • Abstract: Advances in distally protected carotid artery stenting systems and second-generation cerebral thrombectomy devices will help drive strong growth in the US neurointerventional device market over the next five years. The market, which includes endovascular devices for the treatment of cerebral aneurysms, arteriovenous malformations, stroke, and carotid artery disease, is projected to grow at a compound annual rate of 6.5%, and reach more than $846 million by 2018.
      PubDate: Thu, 30 Oct 2014 00:05:02 -040
       
  • SolaranRx: Theranostics For Metastatic Melanoma
    • Abstract: SolaranRx Inc. is jumping on the theranostics bandwagon by tackling the deadly skin cancer melanoma, which for advanced cases has a staggering survival rate of only six months and a one-year mortality of 75%. The company’s lead compound, SRX-1177, is a novel peptide linked to a radioisotope that can preferentially attach to melanocortin-1, a unique receptor overexpressed on melanoma cells.
      PubDate: Thu, 30 Oct 2014 00:00:49 -040
       
  • Niveus Medical: Thermally Enhanced Muscle Stimulation
    • Abstract: The Muscle Stimulation System 110 from Niveus Medical Inc. combines electricity with localized cooling in the treatment area to help prevent atrophy and associated deconditioning in hospital patients facing extended periods of bed rest.
      PubDate: Thu, 30 Oct 2014 00:00:45 -040
       
  • AcuFocus Provides Pair of Solutions for Presbyopia Market
    • Abstract: AcuFocus Inc. is using “small aperture” technology to provide solutions for the vast presbyopia market. The company is poised to potentially be the first to enter the US market with a cornea inlay – pending FDA approval.
      PubDate: Thu, 30 Oct 2014 00:00:31 -040
       
  • Exact Sciences Launches First Stool-Based DNA Screening Test For
           Colorectal Cancer
    • Abstract: With the cost of treating colon cancer in the US projected to reach $20 billion annually by 2020, Exact Sciences hopes to improve colorectal cancer screening and survival rates with Cologuard, the first FDA-cleared noninvasive screening test that analyzes both DNA and blood biomarkers in stool.
      PubDate: Thu, 30 Oct 2014 00:00:18 -040
       
  • St. Jude Medical Expands Presence In Electrophysiology Market With New
           Advanced Ablation Catheter
    • Abstract: St. Jude Medical expands its presence in the electrophysiology market after gaining European regulatory approval of FlexAbility, the company’s next-generation flexible ablation catheter, and expects to receive US FDA 510(k) clearance for the device by year-end.
      PubDate: Thu, 30 Oct 2014 00:00:13 -040
       
  • Medtech Execs On The Move, October 2014
    • Abstract: Recent executive-level company changes and promotions in the medical device and diagnostics industries.
      PubDate: Thu, 30 Oct 2014 00:00:08 -040
       
  • Medical Device Deals Update, October 2014
    • Abstract: Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced September-October 2014.
      PubDate: Thu, 30 Oct 2014 00:00:00 -040
       
  • Innovation And Under-Penetration Driving Global Vascular Access Markets
    • Abstract: With an annual growth of almost 5%, the market for vascular access site repair products is attracting companies with innovative new products. Wider acceptance of new approaches to wound closure by interventionalists and the under-penetration in emerging Asian markets in particular are resulting in an uptake in the use of higher-tech devices and the emergence of local manufacturers.
      PubDate: Tue, 30 Sep 2014 00:05:27 -040
       
  • Who’s Next' Ten Potential Medtech Takeover Targets
    • Abstract: Device firms have already been active with M&A deals in 2014. Here are 10 companies to look for as potential acquisition targets going forward.
      PubDate: Tue, 30 Sep 2014 00:05:12 -040
       
  • Acquisitions, New Technologies Reshaping Advanced Wound Care
    • Abstract: Acquisitions and innovation are rapidly changing the dynamics in the global advanced wound care market, a high need, high growth market estimated at $5.4 billion in 2013. With the number of chronic wounds in major countries estimated at a whopping 26.7 million, the global advanced wound care market is projected to grow at a brisk 6% CAGR, reaching $7.3 billion by 2018.
      PubDate: Tue, 30 Sep 2014 00:05:03 -040
       
  • Google Moves Further Into Medical Device Space
    • Abstract: Google is making further inroads into the medical device space with deals designed to move the company’s two highly touted eyewear products into use by medical professionals. For Google’s smart contact lens, the company has partnered with Alcon to develop a glucose monitoring system, while Google Glass has become part of a project that will allow ambulance teams to transmit live views of patients in transit.
      PubDate: Tue, 30 Sep 2014 00:00:59 -040
       
  • BioVentrix Advances Its Revivent-TC Ventricular
           Enhancement Technology For Heart Failure
    • Abstract: BioVentrix Inc. has its sights set on US market approval for its hybrid transthoracic-endovascular Revivent-TC system, a unique device that enables a minimally invasive approach to treating patients who develop ischemic heart failure following a heart attack.
      PubDate: Tue, 30 Sep 2014 00:00:43 -040
       
  • Neuromod Devices: Self-Administered Neuromodulation For Tinnitus
    • Abstract: Neuromod Devices Ltd. has developed at-home neurostimulation treatment for subjective tinnitus that gradually aids the brain in distinguishing between real and false sounds by simultaneously stimulating the auditory and lingual nerves.
      PubDate: Tue, 30 Sep 2014 00:00:39 -040
       
  • Elute: Bone Filler Provides Sustained Antibiotic Release
    • Abstract: Elute Inc. is developing an antibiotic-releasing bone void filler designed to reduce the incidence of surgical site infections from primary and revised orthopedic procedures.
      PubDate: Tue, 30 Sep 2014 00:00:35 -040
       
  • ActiveProtective Technologies: Wearable Airbag Prevents Fractures
    • Abstract: Imagine wearing a belt containing an airbag that activates when you begin to fall, thus cushioning you from a hip fracture. ActiveProtective Technologies Inc. is developing just such a device that targets the frail and elderly population.
      PubDate: Tue, 30 Sep 2014 00:00:29 -040
       
  • Active Implants' NUsurface Meniscus Implant Starting
           IDE Clinical Trial
    • Abstract: Active Implant LLC is targeting the $1.5 billion annual global market for a meniscus replacement device with its NUsurface Meniscus Implant, and is starting an IDE clinical trial in the US.
      PubDate: Tue, 30 Sep 2014 00:00:21 -040
       
  • Masimo Root Monitoring System Gains FDA Clearance
    • Abstract: Masimo has gained FDA clearance for its Root Patient Monitoring Platform, a noninvasive, continuous monitoring platform with interoperability and technologies that have demonstrated improved patient safety and cost of care.
      PubDate: Tue, 30 Sep 2014 00:00:16 -040
       
  • Medical Device Deals Update, September 2014
    • Abstract: Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced in late July-September 2014.
      PubDate: Tue, 30 Sep 2014 00:00:08 -040
       
  • Medtech Execs On The Move, September 2014
    • Abstract: Recent executive-level company changes and promotions in the medical device and diagnostics industries.
      PubDate: Tue, 30 Sep 2014 00:00:01 -040
       
  • MIS 2014, Part 2: Opportunities And Challenges
    • Abstract: The increasing prevalence of MIS and the opportunity for greater MIS penetration in existing procedures translate into significant growth potential for the MIS products market in the years ahead. Despite some challenges, device manufacturers are driving growth in the market by targeting key procedures and geographies with new robotic surgery systems and robotic-like technologies designed to enable more complex procedures to be performed via an MIS approach.
      PubDate: Thu, 14 Aug 2014 00:05:27 -040
       
  • Peripheral Artery Disease: Treatments And Diagnostics Poised For Growth
    • Abstract: The market for peripheral vascular interventions and diagnostics is poised for significant growth in the years ahead, driven by an aging population and the growing incidence of peripheral vascular disease, along with new technological developments such as drug-eluting balloons, which are inching closer to regulatory approval in the US.
      PubDate: Thu, 14 Aug 2014 00:05:21 -040
       
 
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
Fax: +00 44 (0)131 4513327
 
About JournalTOCs
API
Help
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-2014